Figure 2: Expression of miR-21 and miR-223 in EVs, ASCs and HMEC evaluated by Real-time PCR. (a) expression of miR-21 or miR-223 in b-EVs or FGF-EVs, (mean ±SEM, * - p<0.05 vs. “b-EVs”, n=10); (b) expression of miR-21 or miR-223 in ASCs before or after bFGF stimulation; (c) expression of miR-21 or miR-223 in HMEC after EV addition (mean ±SEM, * - p<0.05 vs. “HMEC”, n=10).